Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Molecular Cell|August 14, 2025
WITHDRAWN: Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic FunctionLixin Wan, Kexin Xu, Yongkun Wei, et al.Molecular Cell|January 21, 2018
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic FunctionLixin Wan, Kexin Xu, Yongkun Wei, et al.Nature Medicine|January 19, 2016
Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitorsYi Du, Hirohito Yamaguchi, Yongkun Wei, et al.Cell Reports. Medicine|July 27, 2025
Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancersMadelaine S Theardy, Mitsunobu Takeda, Alexey Sorokin, et al.Biorxiv : the Preprint Server for Biology|August 30, 2024
Therapeutic targeting of Syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancersMitsunobu Takeda, Madelaine S Theardy, Alexey Sorokin, et al.Nature Communications|November 10, 2019
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancerLei Nie, Yongkun Wei, Fei Zhang, et al.Nature Communications|January 31, 2020
Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancerLei Nie, Yongkun Wei, Fei Zhang, et al.Nature Communications|May 11, 2026
All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancerChing-Fei Li, Yongkun Wei, Heng-Huan Lee, et al.Nature Cancer|October 17, 2022
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complexYu-Yi Chu, Mei-Kuang Chen, Yongkun Wei, et al.Cell Discovery|October 29, 2024
Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancerYohei Saito, Yi Xiao, Jun Yao, et al.Pageof 8